Is Cue Biopharma, Inc. overvalued?

Cue Biopharma, Inc. (CUE) — key valuation metrics and fundamentals.

No verdict

Price

$34.20

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$89.9M

Dividend yield

0.0%

Return on equity

-98.3%

Sector

Healthcare

Fair value compares CUE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks